Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
University of Cambridge · University of South Australia · +29 more institutions
Abstract
Circulating proteins have important functions in inflammation and a broad range of diseases. To identify genetic influences on inflammation-related proteins, we conducted a genome-wide protein quantitative trait locus (pQTL) study of 91 plasma proteins measured using the Olink Target platform in 14,824 participants. We identified 180 pQTLs (59 cis, 121 trans). Integration of pQTL data with eQTL and disease genome-wide association studies provided insight into pathogenesis, implicating lymphotoxin-α in multiple sclerosis. Using Mendelian randomization (MR) to assess causality in disease etiology, we identified both shared and distinct effects of specific proteins across immune-mediated diseases, including…
Citation impact
- FWCI
- 106.26
- Percentile
- 100%
- References
- 69
Authors
46- JHJing Hua ZhaoCorresponding
University of Cambridge
- DSDavid Stacey
University of South Australia, University of Cambridge, South Australian Health and Medical Research Institute
- NENiclas Eriksson
Uppsala University
- EMErin Macdonald-Dunlop
University of Edinburgh
- ÅKÅsa K. Hedman
Karolinska Institutet, Pfizer (Sweden)
Topics & keywords
- Immune system
- Disease
- Immunology
- Biology
- Inflammation
- Computational biology
- Genetics
- Bioinformatics
- Good health and well-being
Funding
- GGlaxoSmithKline
- SMStanley Medical Research Institute
- NBNHS Blood and TransplantAwards: NIHR203337, NIHR BTRU-2014-10024
- WTWellcome TrustAward: BRC-1215-20014
- SGScottish GovernmentAward: CZB/4/710
- NINational Institute for Health and Care ResearchAwards: BTRU-2014-10024, BRC-1215-20014, NIHR BTRU-2014-10024, NIHR203337, NIHR203312
- BHBritish Heart FoundationAwards: RG/18/13/33946, SP/09/002, RG/13/13/30194
- DODepartment of Health and Social Care
- UOUniversity of CambridgeAward: BRC-1215-20014
- ECEuropean CommissionAwards: 018947, H2020, 2020., EU H2020, 2014-2020, 692145, LSHG-CT-2006-018947
- PHPublic Health Agency
- SFStiftelsen för Strategisk ForskningAwards: 2018-05973, KF10-0039, RB13-0197
- ETEesti TeadusagentuurAwards: 2014-2020.4.01.16-0125, MOBTP108, PRG1291, 2014-2020, 2014-2020.4.01.15-0012, PUT1660
- BFBundesministerium für Bildung und ForschungAward: EU H2020
- BFBundesministerium für Gesundheit
- VVetenskapsrådetAwards: 2018-05973, 05973, 2018-
- HZHrvatska Zaklada za Znanost
- TÜTartu Ülikool
- H2Horizon 2020 Framework ProgrammeAwards: 692145, EU H2020
- CSChief Scientist Office, Scottish Government Health and Social Care Directorate
- NBNIHR BioResource
- MRMedical Research CouncilAwards: RG/13/13/30194, HDR-23013, LSHG-CT-2006-018947, MR/L003120/1, MR/S003746/1, NIHR203312, HDR-23007, MR/S003746/1, MC_UU_00007/10, BRC-1215-20014, MR/L003120, MC_UU_00007/10, MR/L003120/1
- EAEngineering and Physical Sciences Research CouncilAwards: EU H2020, H2020
- EAEconomic and Social Research Council
- HAHealth and Social Care Research and Development Division
- HZHelmholtz Zentrum München
- NINIHR Imperial Biomedical Research CentreAward: BRC-1215-20014
- NCNIHR Cambridge Biomedical Research CentreAwards: BRC-1215-20014 and NIHR203312, BRC-1215-20014, NIHR203312
- NCNational Cancer Institute
- MRMedical Research FoundationAwards: MRF-057-0003-RG-PETE-C0799, MRF-042-0001-RG-PETE-C0839